AU2001255449A1 - Mixtures of triblock polyesterpolyethylene glycol copolymers - Google Patents

Mixtures of triblock polyesterpolyethylene glycol copolymers

Info

Publication number
AU2001255449A1
AU2001255449A1 AU2001255449A AU5544901A AU2001255449A1 AU 2001255449 A1 AU2001255449 A1 AU 2001255449A1 AU 2001255449 A AU2001255449 A AU 2001255449A AU 5544901 A AU5544901 A AU 5544901A AU 2001255449 A1 AU2001255449 A1 AU 2001255449A1
Authority
AU
Australia
Prior art keywords
polyesterpolyethylene
triblock
mixtures
glycol copolymers
copolymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255449A
Other languages
English (en)
Inventor
Shih Chung
Ai-Zhi Piao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MacroMed Inc
Original Assignee
MacroMed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MacroMed Inc filed Critical MacroMed Inc
Publication of AU2001255449A1 publication Critical patent/AU2001255449A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
AU2001255449A 2000-04-27 2001-04-18 Mixtures of triblock polyesterpolyethylene glycol copolymers Abandoned AU2001255449A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09559799 2000-04-27
US09/559,799 US7018645B1 (en) 2000-04-27 2000-04-27 Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
PCT/US2001/012576 WO2001082970A1 (en) 2000-04-27 2001-04-18 Mixtures of triblock polyesterpolyethylene glycol copolymers

Publications (1)

Publication Number Publication Date
AU2001255449A1 true AU2001255449A1 (en) 2001-11-12

Family

ID=24235070

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255449A Abandoned AU2001255449A1 (en) 2000-04-27 2001-04-18 Mixtures of triblock polyesterpolyethylene glycol copolymers

Country Status (15)

Country Link
US (2) US7018645B1 (ko)
EP (1) EP1276505B1 (ko)
JP (1) JP4895457B2 (ko)
KR (1) KR100754550B1 (ko)
AR (1) AR028382A1 (ko)
AT (1) ATE342066T1 (ko)
AU (1) AU2001255449A1 (ko)
CA (1) CA2407298C (ko)
CY (1) CY1107540T1 (ko)
DE (1) DE60123772T2 (ko)
DK (1) DK1276505T3 (ko)
ES (1) ES2273834T3 (ko)
PT (1) PT1276505E (ko)
TW (1) TW539718B (ko)
WO (1) WO2001082970A1 (ko)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040185101A1 (en) * 2001-03-27 2004-09-23 Macromed, Incorporated. Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
US6863859B2 (en) * 2001-08-16 2005-03-08 Objet Geometries Ltd. Reverse thermal gels and the use thereof for rapid prototyping
WO2003017972A2 (en) * 2001-08-27 2003-03-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Multi-component polymeric systems with reverse thermal gelation behaviour (e.g. peo-ppo copolymers)
US7649023B2 (en) 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
JP2006506396A (ja) 2002-10-31 2006-02-23 ファイザー・プロダクツ・インク 固体医薬の液体複合体
US20040142039A1 (en) * 2002-10-31 2004-07-22 Pfizer Inc Solid and semi-solid polymeric ionic conjugates
EP1642921B1 (en) * 2003-07-07 2008-08-27 Nof Corporation Triblock copolymer, method for producing the same and biocompatible material
US20060224095A1 (en) * 2005-04-05 2006-10-05 University Of New Hampshire Biocompatible polymeric vesicles self assembled from triblock copolymers
DE102005033101A1 (de) * 2005-07-15 2007-01-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Resorbierbare Polyetherester und ihre Verwendung zur Herstellung von medizinischen Implantaten
WO2007019439A2 (en) * 2005-08-04 2007-02-15 Angiotech International Ag Block copolymer compositions and uses thereof
JP2009540965A (ja) * 2006-06-21 2009-11-26 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 非結合管腔を接合するための組成物および方法
US8608760B2 (en) * 2006-06-21 2013-12-17 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for joining non-conjoined lumens
US8197499B2 (en) * 2006-06-21 2012-06-12 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for joining non-conjoined lumens
US20080140106A1 (en) * 2006-12-12 2008-06-12 Kimberly-Clark Worldwide, Inc. Enhanced cuff sealing for endotracheal tubes
WO2008124127A1 (en) * 2007-04-09 2008-10-16 The Regents Of The University Of California Soft and strong elastomeric compositions from semicrystalline-amorphous polyolefin block copolymers
US7897168B2 (en) 2007-04-13 2011-03-01 Medtronic Vascular, Inc. Degradable polymers incorporating gamma-butyrolactone
US20100204432A1 (en) 2007-05-28 2010-08-12 Husam Younes Biodegradable elastomers prepared by the condensation of an organic di-, tri- or tetra-carboxylic acid and an organic diol
US8172861B2 (en) * 2007-12-20 2012-05-08 Tautona Group, L.P. Compositions and methods for joining non-conjoined lumens
US20090183503A1 (en) * 2008-01-18 2009-07-23 Alberto Verdesi Exhaust apparatus
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
RU2499592C2 (ru) 2008-04-21 2013-11-27 Отономи, Инк. Фармацевтическая композиция для лечения ушных заболеваний
US8784870B2 (en) * 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
JP5421366B2 (ja) 2008-07-21 2014-02-19 オトノミ―，インク． 制御放出性の耳の構造体調節および生来の免疫システム調節化合物および耳の障害の処置のための方法
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US8563037B2 (en) * 2009-02-06 2013-10-22 Tautona Group, L.P. Compositions and methods for joining non-conjoined lumens
DK2478066T3 (en) 2009-09-18 2017-06-19 Protherics Medicines Dev Ltd BAB TRIBLOCK POLYMERS WITH IMPROVED DELIVERY CHARACTERISTICS
US9155722B2 (en) * 2009-09-18 2015-10-13 Protherics Salt Lake City, Inc. Reconstitutable reverse thermal gelling polymers
US8753621B2 (en) * 2009-09-18 2014-06-17 Protherics Salt Lake City, Inc. BAB triblock polymers having improved release characteristics
KR101838303B1 (ko) * 2009-09-18 2018-03-13 비티지 인터내셔널 리미티드 재구성가능한 가역적 열 겔화 고분자
US8551531B2 (en) 2010-04-12 2013-10-08 The Curators Of The University Of Missouri Pentablock polymers
US8614190B2 (en) 2010-06-30 2013-12-24 Industrial Technology Research Institute Thermal responsive composition for treating bone diseases
US9795679B2 (en) 2011-03-31 2017-10-24 Ingell Technologies Holding B.V. Biodegradable compositions suitable for controlled release
ES2820369T3 (es) 2011-03-31 2021-04-20 Ingell Tech Holding B V Composiciones biodegradables adecuadas para liberación controlada
EP2766407B1 (en) * 2011-10-12 2018-06-27 The Curators Of The University Of Missouri Pentablock polymers
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2016520141A (ja) 2013-05-16 2016-07-11 ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリＴｈｅ Ｃｕｒａｔｏｒｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｍｉｓｓｏｕｒｉ ペンタブロックポリマー、製造方法、および薬剤の充填
US10682415B2 (en) 2013-07-22 2020-06-16 Wisconsin Alumni Research Foundation Thermogel formulation for combination drug delivery
MX2016002408A (es) 2013-08-27 2016-10-28 Otonomy Inc Metodos para el tratamiento de trastornos oticos pediatricos.
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
JP6297180B2 (ja) 2014-07-03 2018-03-20 オトノミ—，インク． シプロフロキサシン組成物の滅菌
AU2015316873A1 (en) 2014-09-15 2017-04-06 Novioponics B.V. Composition comprising a hydrogel and pesticides
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
AU2016349415B2 (en) * 2015-11-04 2020-11-26 Ingell Technologies Holding B.V. Compositions comprising triblock copolymers
PT3377041T (pt) 2015-11-16 2023-12-15 Maria Pereira Da Cruz Alves Garcia Método para morcelação e/ou direcionamento de princípios farmaceuticamente ativos ao tecido sinovial
US11246863B2 (en) 2015-12-11 2022-02-15 Alk-Abelló, Inc. Ciprofloxacin otic composition and kits and method for using same
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11040004B2 (en) 2016-09-16 2021-06-22 Otonomy, Inc. Otic gel formulations for treating otitis externa
WO2018183624A1 (en) 2017-03-29 2018-10-04 The Regents Of The University Of Colorado, A Body Corporate Reverse thermal gels and their use as vascular embolic repair agents
JP7187738B2 (ja) * 2017-07-17 2022-12-13 メディンセル 医薬組成物
EP3880754A1 (en) * 2018-11-15 2021-09-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Lactide containing polyester-polyethylene glycol triblock thermoresponsive copolymers
WO2020254249A1 (en) 2019-06-21 2020-12-24 Proqr Therapeutics Ii B.V. Delivery of nucleic acids for the treatment of auditory disorders
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CN113462330B (zh) * 2021-06-30 2022-10-11 佛山南宝高盛高新材料有限公司 一种膏药用热熔胶及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3378250D1 (en) 1982-04-22 1988-11-24 Ici Plc Continuous release formulations
US4438253A (en) 1982-11-12 1984-03-20 American Cyanamid Company Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
GB8416234D0 (en) 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
US4716183A (en) 1985-11-22 1987-12-29 Raychem Corp. Styrene-diene block copolymer compositions
US4892903A (en) * 1986-07-07 1990-01-09 Shell Oil Company Elastomeric fibers, structures fashioned therefrom and elastomeric films
ES2058081T3 (es) 1986-09-05 1994-11-01 American Cyanamid Co Poliesteres que contienen bloques de oxido de alquileno como sistemas de administracion de medicamentos.
JP2670680B2 (ja) 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
JPH064540B2 (ja) * 1988-09-14 1994-01-19 多木化学株式会社 医用組成物
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5674192A (en) * 1990-12-28 1997-10-07 Boston Scientific Corporation Drug delivery
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
US5165713A (en) 1991-07-03 1992-11-24 5Th Boot Industries Inc. Fifth wheel cover
US5330768A (en) 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
GB9211268D0 (en) 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
US5643605A (en) * 1993-10-25 1997-07-01 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
FR2721665B1 (fr) 1994-06-22 1996-07-19 Snecma Ecrous ou vis de freinage et assemblages ainsi constitués.
JPH08176016A (ja) * 1994-12-19 1996-07-09 Univ Miami 生分解可能で注射可能な薬物運搬ポリマー
US5939485A (en) * 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
US6117949A (en) * 1998-10-01 2000-09-12 Macromed, Inc. Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
CN1195788C (zh) * 1997-10-03 2005-04-06 麦克罗梅德公司 具有可逆热胶凝性质的可生物降解低分子量三嵌段聚(丙交酯－共聚－乙交酯)聚乙二醇共聚物
US6004573A (en) * 1997-10-03 1999-12-21 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
GB9814609D0 (en) * 1998-07-07 1998-09-02 Smith & Nephew Polymers
US6451346B1 (en) * 1998-12-23 2002-09-17 Amgen Inc Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
US6287588B1 (en) * 1999-04-29 2001-09-11 Macromed, Inc. Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof

Also Published As

Publication number Publication date
CA2407298C (en) 2010-01-12
US7135190B2 (en) 2006-11-14
JP4895457B2 (ja) 2012-03-14
CA2407298A1 (en) 2001-11-08
EP1276505B1 (en) 2006-10-11
KR100754550B1 (ko) 2007-09-05
AR028382A1 (es) 2003-05-07
EP1276505A1 (en) 2003-01-22
TW539718B (en) 2003-07-01
ES2273834T3 (es) 2007-05-16
CY1107540T1 (el) 2013-03-13
EP1276505A4 (en) 2005-06-29
DE60123772T2 (de) 2007-10-04
WO2001082970A1 (en) 2001-11-08
US20040185104A1 (en) 2004-09-23
DE60123772D1 (de) 2006-11-23
DK1276505T3 (da) 2007-02-12
ATE342066T1 (de) 2006-11-15
JP2003531927A (ja) 2003-10-28
US7018645B1 (en) 2006-03-28
KR20030001446A (ko) 2003-01-06
PT1276505E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
AU2001255449A1 (en) Mixtures of triblock polyesterpolyethylene glycol copolymers
AU2001244579A1 (en) Block copolymer
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001227916A1 (en) Earplug
AU2001294912A1 (en) Hydroxyesters of 7-desmethylrapamycin
AU2001290228A1 (en) Block copolymer
AU2002221980A1 (en) Connection base
AU2002211574A1 (en) Improved guardrail terminals
AU2002214324A1 (en) Medicinal compositions
AU2002221115A1 (en) Medicinal compositions having improved absorbability
AU2002220837A1 (en) Alkylene oxide-lactone copolymers
AU2001241098A1 (en) Composition
AU2001247912A1 (en) Glycol purification
AU2001296017A1 (en) Small switch
AUPR030800A0 (en) Immunomodulatory preparation
AU2001275201A1 (en) Acne-treating composition
AU5029801A (en) Copolymers of allylphosphonium salts
AU2001275723A1 (en) Bougie
AU3943101A (en) Improved keypad
AU2001287852A1 (en) Composition
AUPQ673400A0 (en) Keypad
AU2001235764A1 (en) Compositions
AU2001267541A1 (en) Vaccine composition
AU2001287732A1 (en) Copolycarbonate-based composition
AU2001278859A1 (en) Ubiquitin ligase